PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 185 filers reported holding PROVENTION BIO INC in Q1 2023. The put-call ratio across all filers is 1.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $85,000 | -38.8% | 3,549 | -72.9% | 0.00% | – |
| Q4 2022 | $139,000 | +297.1% | 13,089 | +68.5% | 0.00% | – |
| Q3 2022 | $35,000 | +218.2% | 7,769 | +166.5% | 0.00% | – |
| Q2 2022 | $11,000 | -78.4% | 2,915 | -58.7% | 0.00% | – |
| Q1 2022 | $51,000 | -23.9% | 7,064 | -40.9% | 0.00% | – |
| Q4 2021 | $67,000 | +55.8% | 11,959 | +77.3% | 0.00% | – |
| Q3 2021 | $43,000 | -21.8% | 6,744 | +3.2% | 0.00% | – |
| Q2 2021 | $55,000 | +14.6% | 6,534 | +44.9% | 0.00% | – |
| Q1 2021 | $48,000 | +220.0% | 4,508 | +407.1% | 0.00% | – |
| Q4 2020 | $15,000 | +36.4% | 889 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | -21.4% | 889 | -7.4% | 0.00% | – |
| Q2 2020 | $14,000 | +180.0% | 960 | +92.0% | 0.00% | – |
| Q1 2020 | $5,000 | -64.3% | 500 | -47.4% | 0.00% | – |
| Q4 2019 | $14,000 | +40.0% | 950 | -39.4% | 0.00% | – |
| Q3 2019 | $10,000 | – | 1,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |